Erectile dysfunction clinical trials

Explore recruiting erectile dysfunction clinical trials.

Recruiting erectile dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Erectile dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erectile Dysfunction

Netherlands, Denmark, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Effectiveness and safety of combined autologous Platelet Rich Plasma and Focal Shockwave Therapy for the treatment of erectile dysfunction

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Impact of levothyroxine on erectile function measured by the IIEF-15, EHS, PGIC and EDITS questionnaires in patients with hypothyroidism. Prospective, randomized controlled clinical trial with sildenafil 100

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PARALLEL AND PLACEBO-CONTROLLED SINGLE AND MULTIPLE ASCENDING DOSE TRIAL INVESTIGATING SAFETY, TOLERABILITY AND PHARMACOKINETICS OF LIB-01 IN HEALTHY PARTICIPANTS

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A multicenter, prospective clinical TRrial evaluating patient’s ability to make an independent and safe decision regarding the USe of the medicinal product Sildenafil Polpharma100 mg indicated in the Treatment of erectile dysfunction. TRUST Trial on Responsible Use and Self-assessed Treatment.

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Randomised double-blind clinical trial of Onabotulinumtoxin A injection into the corpora cavernosa in patients with erectile dysfunction refractory to treatment with phosphodiesterase-5 inhibitors

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Erectile dysfunction trials by city

Erectile dysfunction in Toronto Erectile dysfunction in Vancouver Erectile dysfunction in Montreal Erectile dysfunction in Calgary Erectile dysfunction in Edmonton Erectile dysfunction in Ottawa Erectile dysfunction in Winnipeg Erectile dysfunction in Quebec City Erectile dysfunction in Hamilton Erectile dysfunction in Kitchener Erectile dysfunction in London Erectile dysfunction in Halifax Erectile dysfunction in New York Erectile dysfunction in Los Angeles Erectile dysfunction in Chicago Erectile dysfunction in Houston

Other conditions

Fibromyalgia Psoriasis Eczema (atopic dermatitis) Acne Vitiligo Hidradenitis suppurativa Rosacea Alopecia areata Endometriosis Uterine fibroids Menopause Infertility Enlarged prostate (BPH) Breast cancer Prostate cancer Lung cancer Non-small cell lung cancer Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma